KIGALI, 15 January 2021 – The use of unibrol, an antibiotic imported from neighboring Kenya, has been suspended in Rwanda.
Unibrol is administered by mouth and is prescribed to treat intestinal infections, according to its manufacturers, the Kenya-based Universal Corporation Ltd.
Local retailers, pharmacies and patients filed complaints against the drug, leading to an investigation.
Some of the complaints brought to the attention of the FDA “revolved around some tablets in the same pack changing color from white to yellow,” the Rwanda FDA statement added.
The Rwanda Food and Drug Authority (FDA) declared the suspension Wednesday, citing quality concerns.
On 29 December 2020, Rwanda’s FDA recalled two batches of the same antibiotic over quality concerns.
Just before the end of the year, the Rwanda FDA said the suspension will allow the regulator time to conduct an investigation.